A Study of KCT-0809 in Patients With Dry Eye Syndromes

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

Not specified

Conditions
Dry Eye Syndromes
Interventions
DRUG

KCT-0809

DRUG

KCT-0809

DRUG

KCT-0809

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Tohoku, Kanto, Chubu, Kansai, Kyushu Region

All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01211951 - A Study of KCT-0809 in Patients With Dry Eye Syndromes | Biotech Hunter | Biotech Hunter